Xtx Topco LTD Alkermes Plc. Transaction History

Xtx Topco LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$26.4 - $32.56 $483,832 - $596,727	18,327 New	18,327 $496,000
Q3 2023 Nov 13, 2023	BUY	$27.17 - $31.97 $219,289 - $258,029	8,071 Added 59.82%	21,564 $604,000
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $382,391 - $453,769	13,493 New	13,493 $422,000
Q4 2022 Feb 14, 2023	SELL	$21.94 - $26.24 $162,246 - $194,044	-7,395 Reduced 38.8%	11,663 $304,000
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $419,276 - $607,378	19,058 New	19,058 $426,000
Q1 2022 May 13, 2022	SELL	$23.07 - $27.99 $233,468 - $283,258	-10,120 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$21.47 - $32.08 $70,142 - $104,805	3,267 Added 47.67%	10,120 $235,000
Q3 2021 Nov 12, 2021	BUY	$23.37 - $32.13 $160,154 - $220,186	6,853 New	6,853 $211,000

346

183M

209K

89.4K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.52B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.